WALL, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) and large-scale identity solutions, featuring Identity-Bound Biometrics (IBB), will review its Q2 results in a conference call on Friday, August 12th at 10 a.m. after reporting results pre-market. Members of the management team including Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will participate on the call.
| Conference Call Details |
| Date / Time: |
Friday, August 12th at 10 a.m. ET |
| Call Dial In #: |
1-877-418-5460 U.S. or 1-412-717-9594 International |
| Live Webcast / Replay: |
Investor Webcast & Replay– Available for 3 months. |
| Audio Replay: |
1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 6599160 |
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software managing millions of users. Its cloud-based PortalGuard IAM solution provides cost-effective, easy to deploy, convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading Identity-Bound Biometric (IBB) capabilities, enable large-scale Identity-as-a-Service (IDaaS) solutions as well as customized on premises solutions.
